PCV‐13⁽²⁾⁽³⁾ x single dose, followed by PPSV‐23⁽²⁾ 8 weeks later
*Patients post‐hematopoietic stem cell transplant (HSCT) should receive 3 doses of PCV‐13⁽²⁾⁽³⁾, spaced apart by 4 weeks each, starting 3‐9 months after transplant followed by PPSV‐23⁽²⁾ 12‐18 months post‐transplant.
PPSV‐23⁽²⁾ booster x 1 recommended ≥5 years after initial pneumococcal vaccination
(1) Live attenuated vaccine (2) Inactive or component vaccine (3)
Only covered by MSP for certain indications
PPSV‐23: 23 valent pneumococcal polysaccharide vaccine PCV‐13: 13 valent pneumococcal conjugate vaccine